Publication dates

All regions

Clinical Trial Industry, February 2015 Market Reports from Top Publishers

You might be interested in: drug, medical equipment, therapeutics, cancer, cancer drug, plc, heart failure, parkinson's disease, breast cancer, gene therapy, alzheimer's disease, multiple sclerosis, chemotherapy, psoriasis, chronic heart failure.


 
1-10 of about 2 400 reports for Clinical Trial

Neuroendocrine Tumors Drug Pathway Analyzer 2015

Neuroendocrine Tumors Drug Pathway Analyzer 2015

  • $ 749
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 65 targeted molecular therapies known to affect more than 215 specific intracellular signaling pathways ...

Peptides in Oncology: Drug Pathway Analyzer 2015

Peptides in Oncology: Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Developmental stage and status.Example:cancer, myeloma - phase ii clinical trial - activecancer, prostate - phase iii clinical trial - ceased drug descriptionshort introduction to drug ...

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015

  • $ 749
  • Industry report
  • January 2015
  • by Bioseeker

... Including indication, developmental stage and status.Example:cancer, myeloma - phase ii clinical trial - activecancer, prostate - phase iii clinical trial - ceased drug description ...

Proteins in Oncology: Drug Pathway Analyzer 2015

Proteins in Oncology: Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Developmental stage and status.Example:cancer, myeloma - phase ii clinical trial - activecancer, prostate - phase iii clinical trial - ceased drug descriptionshort introduction to drug ...

Biologicals in Oncology: Drug Pathway Analyzer 2015

Biologicals in Oncology: Drug Pathway Analyzer 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

... Developmental stage and status.Example:cancer, myeloma - phase ii clinical trial - activecancer, prostate - phase iii clinical trial - ceased drug descriptionshort introduction to drug ...

CMIC Holdings Co. Ltd. (2309) - Financial and Strategic SWOT Analysis Review

CMIC Holdings Co. Ltd. (2309) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary CMIC Holdings Co. Ltd. (CMIC) is a contract research organization. The organization provides medical research related services to pharmaceuticals and medical organizations. It offers CRO business, ...

Genovate Biotechnology Co., LTD. (Symbol:4130) SWOT Analysis, Strategy, Revenues and Profits

Genovate Biotechnology Co., LTD. (Symbol:4130) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Out new drug and new formulation development, and undertakes cgmp drug manufacturing, product registration, clinical trials, drug marketing and distribution. It offers products such as antimicrobials ...

Hadasit Bio-Holdings Ltd. (Symbol:HDST) SWOT Analysis, Strategy, Revenues and Profits

Hadasit Bio-Holdings Ltd. (Symbol:HDST) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For phase ii by the portfolio companies. Hadasit's preparations include pre-clinical trials, manufacturing, regulatory and business development tasks. The company's portfolio of companies includes prot ...

HST Global Inc. (Symbol:HSTC) SWOT Analysis, Strategy, Revenues and Profits

HST Global Inc. (Symbol:HSTC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For patients. It operates through wellness centers and provides cancer care services. The organization's homeopathic and alternative clinical trial products are for the treatment of late stage cancer. Hst global ...

PAION AG (Symbol:PA8) SWOT Analysis, Strategy, Revenues and Profits

PAION AG (Symbol:PA8) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Thrombotic diseases, blood vessel related diseases and central nervous system disorders. The company also offers phase-iii clinical trials for the cure of anesthesia and procedural sedation, and phase ...

About 7 100 reports for Clinical Trial

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

99 Companies for Clinical Trial

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.